Literature DB >> 22426609

Difficulties with defining lymphoedema after axillary dissection for breast cancer.

Muhammad Asim1, Alvin Cham, Sharmana Banerjee, Rachael Nancekivell, Gaelle Dutu, Catherine McBride, Shelley Cavanagh, Ross Lawrenson, Ian Campbell.   

Abstract

AIM: Axillary lymph node dissection(AND) is a common treatment for breast cancer. An important side effect of the surgery is lymphoedema (LO). The primary aims of this study were to assess the local prevalence of LO in patients who had undergone AND and how the subjective symptoms described by patients compare with objective measurements. Secondary aims were to investigate the relationship between risk factors and the prevalence of LO and to establish an easy and convenient way to detect LO patients in surgical clinics.
METHOD: Eligible women after AND for breast cancer underwent three circumference measurements on the operated and non operated (control) arm. LO was defined as one or more measurements with an increase ≥7.5% than control after dominant arm correction. Questionnaires were used to assess severity of symptoms related to lymphoedema. 73 patients also had serial measurements in arms and change in arm volume in operated arm was calculated using Casley-Smith method and LO was defined as ≥20% increase in volume.
RESULTS: 193 women with AND were analysed. Mean age was 61 years and mean time since surgery was 56 months. The overall prevalence of LO was 23.3%. LO prevalence by arm volume was 8.2%. Using volume as the standard, an arm circumference increase of ≥7.5% and ≥10% showed a sensitivity and specificity of 83% and 81%, and 66% and 89% respectively. Significant risk factors for LO were age, radiotherapy and infection to the operated arm
CONCLUSION: Circumference measures are a simple office method of screening for LO. A patient history and ≥10% increase in any circumference is optimal for determining LO after AND.

Entities:  

Mesh:

Year:  2012        PMID: 22426609

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  7 in total

1.  Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study.

Authors:  Cynthia L Miller; Amy S Colwell; Nora Horick; Melissa N Skolny; Lauren S Jammallo; Jean A O'Toole; Mina N Shenouda; Betro T Sadek; Meyha N Swaroop; Chantal M Ferguson; Barbara L Smith; Michelle C Specht; Alphonse G Taghian
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

2.  Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?

Authors:  Michelle C Specht; Cynthia L Miller; Tara A Russell; Nora Horick; Melissa N Skolny; Jean A O'Toole; Lauren S Jammallo; Andrzej Niemierko; Betro T Sadek; Mina N Shenouda; Dianne M Finkelstein; Barbara L Smith; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2013-08-04       Impact factor: 4.872

3.  Analysis of factors contributing to severity of breast cancer-related lymphedema.

Authors:  Michelle Coriddi; Ibrahim Khansa; Julie Stephens; Michael Miller; James Boehmler; Pankaj Tiwari
Journal:  Ann Plast Surg       Date:  2015-01       Impact factor: 1.539

4.  Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Rehabil Oncol       Date:  2017-06-30

Review 5.  Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Phys Ther       Date:  2017-07-01

6.  Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.

Authors:  Yan Lin; Ying Xu; Changjun Wang; Yu Song; Xin Huang; Xiaohui Zhang; Xi Cao; Qiang Sun
Journal:  Breast Cancer       Date:  2021-06-09       Impact factor: 4.239

Review 7.  Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review.

Authors:  G David Baxter; Lizhou Liu; Simone Petrich; Angela Spontelli Gisselman; Cathy Chapple; Juanita J Anders; Steve Tumilty
Journal:  BMC Cancer       Date:  2017-12-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.